Across TCGA pan-cancer cohorts, TOPORSLP RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated TOPORSLP data layer.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher TOPORSLP RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated TOPORSLP expression acts as an unfavorable survival marker, although some lineages such as BLCA and LUSC show a favorable association.
KIRC, READ, and MESO are the cancer types where TOPORSLP RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.